Evolution of P[8], P[4], and P[6] VP8* genes of human rotaviruses globally reported during 1974 and 2017: possible implications for rotavirus vaccines in development

References

• Tate JE, Burton AH, Boschi-Pinto C, Parashar UD. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clin Infect Dis. 2016;62(Suppl 2):S96–s105. doi:10.1093/cid/civ1013.
   PubMed Web of Science ®Google Scholar
• Zeller M, Donato C, Trovao NS, Cowley D, Heylen E, Donker NC, McAllen JK, Akopov A, Kirkness EF, Lemey P, et al. Genome-wide evolutionary analyses of g1P[8] strains isolated before and after rotavirus vaccine introduction. Genome Biol Evol. 2015;7:2473–83. doi:10.1093/gbe/evv157.
   PubMed Web of Science ®Google Scholar
• Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Banyai K, Brister JR, Buesa JEsona MD, Estes MK, Gentsch JR, et al. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol. 2011;156:1397–413. doi:10.1007/s00705-011-1006-z.
   PubMed Web of Science ®Google Scholar
• Bowen MD, Mijatovic-Rustempasic S, Esona MD, Teel EN, Gautam R, Sturgeon M, Azimi PH, Baker CJ, Bernstein DI, Boom JA, et al. Rotavirus strain trends during the postlicensure vaccine era: United States, 2008–2013. J Infect Dis. 2016;214:732–38. doi:10.1093/infdis/jiw233.
   PubMed Web of Science ®Google Scholar
• Leshem E, Lopman B, Glass R, Gentsch J, Banyai K, Parashar U, Patel M. Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14:847–56. doi:10.1016/S1473-3099(14)70832-1.
   PubMed Web of Science ®Google Scholar
• Heylen E, Zeller M, Ciarlet M, Lawrence J, Steele D, Van Ranst M, Matthijnssens J, Human P, et al. Human P[6] rotaviruses from Sub-Saharan Africa and Southeast Asia are closely related to those of human P[4] and P[8] rotaviruses circulating worldwide. J Infect Dis. 2016;214:1039–49. doi:10.1093/infdis/jiw247.
   PubMed Web of Science ®Google Scholar
• Dormitzer PR, Nason EB, Prasad BV, Harrison SC. Structural rearrangements in the membrane penetration protein of a non-enveloped virus. Nature. 2004;430:1053–58. doi:10.1038/nature02836.
   PubMed Web of Science ®Google Scholar
• Venkataram Prasad BV, Shanker S, Hu L, Choi JM, Crawford SE, Ramani S, Czako R, Atmar RL, Estes MK. Structural basis of glycan interaction in gastroenteric viral pathogens. Curr Opin Virol. 2014;7:119–27. doi:10.1016/j.coviro.2014.05.008.
   PubMed Web of Science ®Google Scholar
• Settembre EC, Chen JZ, Dormitzer PR, Grigorieff N, Harrison SC. Atomic model of an infectious rotavirus particle. Embo J. 2011;30:408–16. doi:10.1038/emboj.2010.322.
   PubMed Web of Science ®Google Scholar
• Parashar UD, Johnson H, Steele AD, Tate JE. Health impact of rotavirus vaccination in developing countries: progress and way forward. Clin Infect Dis. 2016;62(Suppl 2):S91–5. doi:10.1093/cid/civ1015.
   PubMed Web of Science ®Google Scholar
• Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376:606–14. doi:10.1016/S0140-6736(10)60889-6.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362:289–98. doi:10.1056/NEJMoa0904797.
   PubMed Web of Science ®Google Scholar
• Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Thiem VD, Luby SP, Coia ML, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376:615–23. doi:10.1016/S0140-6736(10)60755-6.
   PubMed Web of Science ®Google Scholar
• Desselberger U. Differences of rotavirus vaccine effectiveness by country: likely causes and contributing factors. Pathogens. 2017;6:pii: E65.
   PubMed Web of Science ®Google Scholar
• Velasquez DE, Parashar U, Jiang B. Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors. Expert Rev Vaccines. 2018;17:145–61. doi:10.1080/14760584.2018.1418665.
   PubMed Web of Science ®Google Scholar
• Azevedo MS, Gonzalez AM, Yuan L, Jeong KI, Iosef C, Van Nguyen T, Lovgren-Bengtsson K, Morein B, Saif LJ. An oral versus intranasal prime/boost regimen using attenuated human rotavirus or VP2 and VP6 virus-like particles with immunostimulating complexes influences protection and antibody-secreting cell responses to rotavirus in a neonatal gnotobiotic pig model. Clin Vaccine Immunol. 2010;17:420–28. doi:10.1128/CVI.00395-09.
   PubMed Web of Science ®Google Scholar
• Blazevic V, Lappalainen S, Nurminen K, Huhti L, Vesikari T. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis. Vaccine. 2011;29:8126–33. doi:10.1016/j.vaccine.2011.08.026.
   PubMed Web of Science ®Google Scholar
• Li T, Lin H, Zhang Y, Li M, Wang D, Che Y, Zhu Y, Li S, Zhang J, Ge S, et al. Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles. Vaccine. 2014;32:1921–31. doi:10.1016/j.vaccine.2014.01.093.
   PubMed Web of Science ®Google Scholar
• Wen X, Cao D, Jones RW, Hoshino Y, Yuan L. Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic. Hum Vaccin Immunother. 2015;11:2483–89. doi:10.1080/21645515.2015.1054583.
   PubMed Web of Science ®Google Scholar
• Zeller M, Patton JT, Heylen E, De Coster S, Ciarlet M, Van Ranst M, Matthijnssens J. Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J Clin Microbiol. 2012;50:966–76. doi:10.1128/JCM.05590-11.
   PubMed Web of Science ®Google Scholar
• Dennis AF, McDonald SM, Payne DC, Mijatovic-Rustempasic S, Esona MD, Edwards KM, Chappell JD, Patton JT. Molecular epidemiology of contemporary G2P[4] human rotaviruses cocirculating in a single U.S. community: footprints of a globally transitioning genotype. J Virol. 2014;88:3789–801. doi:10.1128/JVI.03516-13.
   PubMed Web of Science ®Google Scholar
• Zhang S, McDonald PW, Thompson TA, Dennis AF, Akopov A, Kirkness EF, Seheri ML, Steele AD, Wentworth DE, Mphahlele MJ. Analysis of human rotaviruses from a single location over an 18-year time span suggests that protein coadaption influences gene constellations. J Virol. 2014;88:9842–63. doi:10.1128/JVI.01562-14.
   PubMed Web of Science ®Google Scholar
• Magagula NB, Esona MD, Nyaga MM, Stucker KM, Halpin RA, Stockwell TB, et al. Whole genome analyses of G1P[8] rotavirus strains from vaccinated and non-vaccinated South African children presenting with diarrhea. J Med Virol. 2015;87:79–101. doi:10.1002/jmv.23971.
   PubMed Web of Science ®Google Scholar
• Kulkarni R, Arora R, Arora R, Chitambar SD. Sequence analysis of VP7 and VP4 genes of G1P[8] rotaviruses circulating among diarrhoeic children in Pune, India: a comparison with Rotarix and RotaTeq vaccine strains. Vaccine. 2014;32(Suppl 1):A75–83. doi:10.1016/j.vaccine.2014.03.080.
   PubMed Web of Science ®Google Scholar
• Morozova OV, Sashina TA, Fomina SG, Novikova NA. Comparative characteristics of the VP7 and VP4 antigenic epitopes of the rotaviruses circulating in Russia (Nizhny Novgorod) and the Rotarix and RotaTeq vaccines. Arch Virol. 2015;160:1693–703. doi:10.1007/s00705-015-2439-6.
   PubMed Web of Science ®Google Scholar
• Jiang V, Jiang B, Tate J, Parashar UD, Patel MM. Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin. 2010;6:532–42. doi:10.4161/hv.6.7.11278.
   PubMed Web of Science ®Google Scholar
• Groome MJ, Koen A, Fix A, Page N, Jose L, Madhi SA, McNeal M, Dally L, Cho I, Power M, et al. Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2017;17:843–53. doi:10.1016/S1473-3099(17)30242-6.
   PubMed Web of Science ®Google Scholar
• Fix A, Groome M, Fairlie L, Morrison J, Koen A, Masenya M, Page N, Jose L, Madhi S, McNeal M, et al. Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine. 13th International Double-Stranded RNA Virus Symposium Abstract book 2018:p157; Houffalize, Belgium.
   Google Scholar
• Clarke E, Desselberger U. Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol. 2015;8:1–17. doi:10.1038/mi.2014.114.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22. doi:10.1056/NEJMoa052434.
   PubMed Web of Science ®Google Scholar
• Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life. Vaccine. 2014;32(Suppl 1):A110–6. doi:10.1016/j.vaccine.2014.04.079.
   PubMed Web of Science ®Google Scholar
• Velasquez DE, Parashar UD, Jiang B. Strain diversity plays no major role in the varying efficacy of rotavirus vaccines: an overview. Infect Genet Evol. 2014;28:561–71. doi:10.1016/j.meegid.2014.10.008.
   PubMed Web of Science ®Google Scholar
• Desselberger U, Huppertz HI. Immune responses to rotavirus infection and vaccination and associated correlates of protection. J Infect Dis. 2011;203:188–95. doi:10.1093/infdis/jiq031.
   PubMed Web of Science ®Google Scholar
• Arias CF, Lopez S, Mascarenhas JD, Romero P, Cano P, Gabbay YB, De Freitas RB, Linhares AC. Neutralizing antibody immune response in children with primary and secondary rotavirus infections. Clin Diagn Lab Immunol. 1994;1:89–94.
   PubMedGoogle Scholar
• Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM, et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med. 1996;335:1022–28. doi:10.1056/NEJM199610033351404.
   PubMed Web of Science ®Google Scholar
• Gladstone BP, Ramani S, Mukhopadhya I, Muliyil J, Sarkar R, Rehman AM, et al. Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med. 2011;365:337–46. doi:10.1056/NEJMoa1006261.
   PubMed Web of Science ®Google Scholar
• Nair N, Feng N, Blum LK, Sanyal M, Ding S, Jiang B, Sen A, Morton JM, He XS, Robinson WH, Greenberg HB. VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans. Sci Transl Med. 2017;9.
   Web of Science ®Google Scholar
• Felix-Valenzuela L, Cooley-Garcia DP, Cano-Rangel MA, Durazo-Arvizu ML, Mata-Haro V. Predominance of G9P[4] rotavirus from children with acute gastroenteritis in Northwestern Mexico. Intervirology. 2016;59:228–33. doi:10.1159/000464132.
   PubMed Web of Science ®Google Scholar
• Seheri LM, Magagula NB, Peenze I, Rakau K, Ndadza A, Mwenda JM, Weldegebriel G, Steele AD, Mphahlele MJ. Rotavirus strain diversity in Eastern and Southern African countries before and after vaccine introduction. Vaccine. 2018;36:7222–30. doi:10.1016/j.vaccine.2017.11.068.
   PubMedGoogle Scholar
• Xu C, Fu J, Ai J, Zhang J, Liu C, Huo X, Bao, C, Zhu, Y. Phylogenetic analysis of human G9P[8] rotavirus strains circulating in Jiangsu, China between 2010 and 2016. J Med Virol. 2018;90:1461–70. doi:10.1002/jmv.25214.
   PubMed Web of Science ®Google Scholar